advertisement

---

Nitta E 15

Showing records 1 to 15 | Display all abstracts from Nitta E

69028 Relationship between oxygen saturation of the retinal vessels and visual field defect in glaucoma patients: comparison with each hemifield
Shimazaki T
Acta Ophthalmologica 2016; 94: e683-e687

---

69364 Additive Intraocular Pressure Lowering Effects of the Rho Kinase Inhibitor, Ripasudil in Glaucoma Patients Not Able to Obtain Adequate Control After Other Maximal Tolerated Medical Therapy
Sato S
Advances in Therapy 2016; 33: 1628-1634

---

69420 Estimating the rate of retinal ganglion cell loss to detect glaucoma progression: An observational cohort study
Hirooka K
Medicine 2016; 95: e4209

---

69364 Additive Intraocular Pressure Lowering Effects of the Rho Kinase Inhibitor, Ripasudil in Glaucoma Patients Not Able to Obtain Adequate Control After Other Maximal Tolerated Medical Therapy
Hirooka K
Advances in Therapy 2016; 33: 1628-1634

---

69420 Estimating the rate of retinal ganglion cell loss to detect glaucoma progression: An observational cohort study
Izumibata S
Medicine 2016; 95: e4209

---

69028 Relationship between oxygen saturation of the retinal vessels and visual field defect in glaucoma patients: comparison with each hemifield
Hirooka K
Acta Ophthalmologica 2016; 94: e683-e687

---

69420 Estimating the rate of retinal ganglion cell loss to detect glaucoma progression: An observational cohort study
Ukegawa K
Medicine 2016; 95: e4209

---

69364 Additive Intraocular Pressure Lowering Effects of the Rho Kinase Inhibitor, Ripasudil in Glaucoma Patients Not Able to Obtain Adequate Control After Other Maximal Tolerated Medical Therapy
Nitta E
Advances in Therapy 2016; 33: 1628-1634

---

69028 Relationship between oxygen saturation of the retinal vessels and visual field defect in glaucoma patients: comparison with each hemifield
Nakano Y
Acta Ophthalmologica 2016; 94: e683-e687

---

69364 Additive Intraocular Pressure Lowering Effects of the Rho Kinase Inhibitor, Ripasudil in Glaucoma Patients Not Able to Obtain Adequate Control After Other Maximal Tolerated Medical Therapy
Ukegawa K
Advances in Therapy 2016; 33: 1628-1634

---

69420 Estimating the rate of retinal ganglion cell loss to detect glaucoma progression: An observational cohort study
Nitta E
Medicine 2016; 95: e4209

---

69028 Relationship between oxygen saturation of the retinal vessels and visual field defect in glaucoma patients: comparison with each hemifield
Nitta E; Ukegawa K
Acta Ophthalmologica 2016; 94: e683-e687

---

69364 Additive Intraocular Pressure Lowering Effects of the Rho Kinase Inhibitor, Ripasudil in Glaucoma Patients Not Able to Obtain Adequate Control After Other Maximal Tolerated Medical Therapy
Tsujikawa A
Advances in Therapy 2016; 33: 1628-1634

---

69420 Estimating the rate of retinal ganglion cell loss to detect glaucoma progression: An observational cohort study
Tsujikawa A
Medicine 2016; 95: e4209

---

69028 Relationship between oxygen saturation of the retinal vessels and visual field defect in glaucoma patients: comparison with each hemifield
Sato S; Tsujikawa A
Acta Ophthalmologica 2016; 94: e683-e687

---